Go back to Resources

217-OR: Islet Transplantation vs. Standard of Care for Type 1 Diabetes Complicated by Severe Hypoglycemia from the Collaborative Islet Transplant Registry (CITR) and T1D Exchange (T1DX) Registry

Authors:

Secondary:

Volume:

Pagination:

Journal:

Location:

URL:

DOI:

Abstract:

Go back to Resources

Go back to Resources

Who Is the Ideal Patient for Alloislet Transplant? Predictive Models for Successful Transplant Outcomes from the CITR

Authors:

Secondary:

Location:

URL:

Go back to Resources

Go back to Resources

6.10 - COLLABORATIVE ISLET TRANSPLANT REGISTRY (CITR) UPDATE

Authors:

Secondary:

Location:

URL:

Go back to Resources

Go back to Resources

Primary Graft Function Predicted 5-Year Outcomes Of Islet Allotransplantation: A Retrospective Cohort Study From The Citr In 1210 T1d Patients

Authors:

Secondary:

Location:

URL:

Go back to Resources

Go back to Resources

Impact of early graft function on the outcome of islet allotransplantation in 1210 T1D from the international registry

Authors:

Secondary:

Location:

URL:

Go back to Resources

Go back to Resources

Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation

Authors:

Volume:

Pagination:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

Predictive Value of C-Peptide Measures for Clinical Outcomes of beta-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR)

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Go back to Resources

CureAA - A Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) #2207

Authors:

Location:

URL:

Go back to Resources